FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21216311000001107: Magnesium oxide 160mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70577501000001117 Magnesium oxide 160mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70577601000001118 Magnesium oxide 160mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium oxide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Is a Magnesium oxide true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Is a Product containing magnesium oxide false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has active ingredient Magnesium oxide false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium oxide 160mg tablets 1 tablet Has VMP True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets (Special Order) Is a True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier
Oromag 160 tablets (Fontus Health Ltd) Is a True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 120 tablet Has VMP True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet Has VMP True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) Is a True Magnesium oxide 160mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start